Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer

PURPOSE: We sought to investigate the safety and efficacy of gemcitabine, cisplatin, and lapatinib (GCL) as neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC) planned for radical cystectomy. MATERIALS AND METHODS: Four cycles of GCL were administered as neoadjuvant therapy fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Narayan, Vivek, Mamtani, Ronac, Keefe, Stephen, Guzzo, Thomas, Malkowicz, S. Bruce, Vaughn, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946374/
https://www.ncbi.nlm.nih.gov/pubmed/26639198
http://dx.doi.org/10.4143/crt.2015.405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946374/
https://www.ncbi.nlm.nih.gov/pubmed/26639198
http://dx.doi.org/10.4143/crt.2015.405

Ejemplares similares